Trial Condition(s):

Hypertension

The Real-Life Efficacy and Safety of Telmisartan in Patients with Arterial Hypertension (METABOLIC)

Bayer Identifier:

12729

ClinicalTrials.gov Identifier:

NCT00471003

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The main purpose of this study is to asses the efficacy and safety of telmisartan, with the special attention on the influence of telmisartan on selected metabolic parameters of patients.

Inclusion Criteria
- Age over 18
 - Untreated or ineffectively treated arterial hypertension
Exclusion Criteria
- Cholestatic disorders and severe hepatic failure
 - Allergy to telmisartan
 - Pregnancy and lactation period

Trial Summary

Enrollment Goal
5448
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Croatia

Status
Completed
 
Locations

Investigative Site

Many locations, Slovenia

Status
Completed
 
Locations

Investigative Site

Many locations, Poland

Status
Completed
 
Locations

Investigative Site

Many locations, Slovakia

Status
Completed
 

Trial Design